This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Fluoropolymers in Healthcare Market

Market Insights on Fluoropolymers in Healthcare covering sales outlook, demand forecast & up-to-date key trends

Fluoropolymers in Healthcare Market By Product Type (PTFE, PVDF, PVF, FEP, PCTFE, PFA), Application (Medical Devices, Hospital Disposable, Pharma Packaging) & Region - Forecast to 2020-2030

Introduction

New materials that exhibit suitable properties for particular application have resulted in increasing interest among healthcare professionals and patients over past few decades.

Among them, fluoropolymers (FP) are relevant niche candidates that are equipped with favorable properties such as chemical inertness (to oils, solvents, and acids), thermal stability, and durability.

Increased emphasis on health and hygiene to avoid potential COVID-19 contagion has bolstered sales of various hospital disposables. In addition, governments and health authorities are leveraging federal powers to influence manufacturers to ramp up production of hospital disposables at significant pace.

As such, the COVID-19 pandemic has fueled sales of hospital disposables and medical equipment as epidemiological numbers continue to surge. These trends will work in favor of fluoropolymers in healthcare market. By 2030, sales of fluoropolymers in healthcare industry will register revenues over US$ 900 Mn.

Customize this Report

Let us know your requirement to get
100% FREE customization

Growing Focus Toward Medical Devices

The global medical device industry is witnessing tech-enabled advances and continuous innovations. As such, investments in R&D in this domain have surged by nearly 2X over recent past.

According to recent estimates, firms in medical device industry spend about 7% of their yearly revenue on R&D activities, echoing competitive nature of this sphere. Further, these estimates suggest that adoption of fluoropolymers in medical devices is prominent in developed regions, especially the US.

While hospital disposables and pharma packaging have been conventional applications for fluoropolymer manufacturers, adoption in medical devices such as catheters, and introducers will rise at rapid CAGR in coming years.

Expanding Revenue Pool

The COVID-19 pandemic and subsequent rising hospital admissions across the globe have considerably fueled the demand for medical disposables. The World Health Organization (WHO) has instructed industries and regulatory bodies to scale up manufacturing of personal protective equipment (PPE) such as medical gloves, hospital gowns, and face shields by 40% to cater to increasing global demand.

FMI also finds that rise in demand for such accessories has fueled their prices significantly. Case in point, price of hospital gowns has surged two-fold and that of surgical masks has increased six-fold. Further, the WHO has shipped nearly 500, 000 sets of PPE to about 47 countries. As such, sales of fluoropolymers have seen notable rise during the COVID-19 pandemic.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Region-wise Analysis

East Asia Fluoropolymers in Healthcare Market

East Asia continues to engage stakeholders in fluoropolymers in healthcare market over following decade. The WHO reveals that 10 out of every 100 hospitalized patients in developing countries at any given time will acquire at least one healthcare-associated infection (HAI). Further, prevalence of HAIs is significantly higher in middle- and low-income countries (LMIC).

In addition, East Asia has been among the worst affected regions by COVID-19 pandemic. China and South Korea have registered notable rise in prevalence of COVID-19 spread. Densely populated pockets in these regions are triggering the risk for community transmission of the virus.

These broad factors will drive East Asia fluoropolymers in healthcare market. While China and South Korea collectively capture around 90% of overall regional market value, Japan will reflect potential growth prospects.

Europe Fluoropolymers in Healthcare Market

Europe follows East Asia in global fluoropolymers in healthcare market in terms of revenue share and CAGR.  Pharmaceutical industry is among key-performing high-tech industries in Europe.

Medicines regulatory system of the region is based on network of 50 regulatory bodies from the European Commission, 31 European Economic Area (EEA) countries, and the European Medicines Agency (EMA).

Plastic bottles are utilized in large quantities for oral medicines distributed via prescription and bulk dose volumes to retail and mail order pharmacies. Moreover, plastic bottles find immense use in several applications as containers for over-the-counter (OTC) drugs distributed in capsules and tablets.

While Germany represents fluoropolymers in healthcare market in Europe, players are also generating substantial revenues from Italy and the UK.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

North America Fluoropolymers in Healthcare Market

The fluoropolymers in healthcare market in North America is receiving major impetus from notable rise in hospital acquired infections (HAIs) and medical surgeries. HAIs result in myriads of mortalities and cost the US healthcare system significantly every year.

As such, the US Department of Health and Human Services (HHS) has recognized reduction of HAIs as Agency Priority Goal (APG). In addition, the US tops the list of active COVID-19 cases, thus, triggering the demand for hospital disposables. This, in turn, will drive adoption of fluoropolymers in healthcare systems.

The US will remain at forefront of regional market, as the country account for sales of about 9 out of 10 fluoropolymers, while market in Canada will fade in coming years.

Category-wise Insights

Product

About half of medical equipment globally contains polytetrafluoroethylene (PTFE) or teflon coatings, owing to their umpteen resistance against corrosion and various chemical agents. Healthcare professionals generally prefer medical equipment that are coated with teflon. In laboratories, teflon plays crucial role in maintaining safe and bacteria-free environment.

Moving ahead, in certain labs, microbial cultures are created for research purposes. Myriads of utensils utilized by healthcare professionals as well as platforms and analyzing tables are coated with teflon as the material does not impede development of bacteria and microbes.

Application

Increasing prevalence of HAIs and pandemic-related diseases has compelling consumers to resort to hospital disposables. The US Department of Health & Human Services (HHS) states that about 4% of total inpatients suffer from infection due to hospital care, at any given time.

Fluoropolymers in Healthcare Market Download Report Brochure

Moreover, sales of hospital disposables have reached their peak amidst the COVID-19 pandemic. Among hospital disposables, medical gloves and blood bags continue to account for greater demand. Moving ahead, market players will hurt their revenue pool if they do not place their bets on medical devices.

Competitive Intelligence

Top 10 players capture about 40-45% of overall revenue. Fluoropolymer manufacturers are focusing on developing multipurpose products such as standard as well as customized or compounded products.

In addition, they are looking to equip their offerings with innovate technologies to cater to high-end applications. Mergers & acquisitions (M&A) will be another key focus point for global market players.

DIC Corporation has developed novel polyester plasticizer made from biomass resources and has earned the “Biomass 100%” Biomass Mark.

Korean joint venture - Mitsui Chemicals & SKC Polyurethanes Inc. – has manufactured ECONYKOL™ bio-polyol, which is raw material for plant-sourced biomass plastics that help curb ecological impact. The product has been adopted for polyurethane (PU) cushioning in seats of Robocar™ self-driving car.

Honeywell International Inc. has launched breakthrough platform of liquid heat transfer agents that cool high-performance electronics more effectively compared to conventional techniques that utilize water and air. IN addition, the company has rolled out 30 Series IP Cameras, which is a new set of video cameras that steps up infrastructure safety and security via advanced analytics and secure channel encryption.

3M Company has acquired Acelity, Inc. and its KCI subsidiaries. Further, the company has entered into royalty-bearing patent license agreement with LG-Innotek (LGIT) to leverage 3M’s metal mesh technology.

Daikin Industries Ltd. has acquired Heroflon, whose product assembly consists of micro-powders and fluoropolymer compounds derived from PTFE.

Lonza has entered into collaboration with Mesoblast to commercially develop Mesoblast’s lead allogeneic (off-the-shelf) cell therapy product - remestemcel-L - for pediatric steroid-refractory acute graft versus host disease (aGVHD).

In addition to these, some other key players in fluoropolymers in healthcare market include

  • DIC Corporation
  • AGC Inc.
  • Dongyue Group Ltd.
  • Solvay S.A.
  • PolyOne Corporation
  • Kaneka Corp.
  • Arkema Group
  • Saint Gobain S.A.
  • The Chemours Company

Fluoropolymers in Healthcare Market Report: Scope

Attribute

Details

Forecast Period

2020-2030

Historical Data Available for

2015-2019

Market Analysis

USD Million for value and Tons for Volume

Key Regions Covered

North America, Latin America, Europe. South Asia & Pacific, East Asia, and Middle East & Africa (MEA)

Key Countries Covered

US, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, BENELUX, China, Japan, South Korea, India, ASEAN, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, Israel, South Africa

Key Segments Covered

Product, Application, and Region

Key Companies Profiled

DIC Corporation, AGC Inc., Solvay S.A., Daikin Industries Ltd., Honeywell International Inc., Arkema Group, 3M Company, and The Chemours Company (only indicative list)

Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments

Product Type:

  • PTFE
  • PVDF
  • PVF
  • FEP
  • PCTFE
  • PFA
  • Others

Application:

  • Medical Devices
  • Hospital Disposable
  • Pharma Packaging

Regional Outlook:

  • North America (US, and Canada)
  • Latin America (Brazil, and Mexico)
  • Europe (Germany, UK, Russia, France, and Italy)
  • South Asia & Pacific (India, Indonesia, Thailand, Australia and New Zealand)
  • East Asia (China, Japan, and South Korea)
  • Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)

Frequently Asked Questions

The global fluoropolymers in healthcare market will value around US$ 927 Mn in 2030. The growth rate for the market will be 4.7 % CAGR during 2020-2030.

East Asia represents the largest market globally, followed by Europe, owing to rising government investments in patient-centric care models.

The market is fairly consolidated with leading players including, DIC Corporation, AGC Inc., and Solvay S.A., accounting for prominent share in market revenue.

Companies generally offer fluoropolymers in healthcare for several applications such as medical devices, hospital disposables, and pharma packaging. While adoption in hospital disposables will remain high, usage in pharma packaging will pick momentum in coming years.

Market players continue to bank on polytetrafluoroethylene (PTFE) as preferred fluoropolymers. That said, they are also turning to polyvinyl fluoride (PVF) and perfluoroalkoxy alkanes (PFA).

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Taxonomy

    2.2. Market Definition 

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development Trends

4. Key Success Factors

    4.1. Strategic Promotional Strategies

5. Global Fluoropolymers Market for Healthcare Demand Analysis 2015 – 2019 and Forecast, 2020 – 2030

    5.1. Historical Market Volume (Tons) Analysis, 2015 – 2019

    5.2. Current and Future Market Volume (Tons) Projections, 2020 – 2030

    5.3. Y-o-Y Growth Trend Analysis

6. Global Fluoropolymers Market for Healthcare - Pricing Analysis

    6.1. Regional Pricing Analysis By product Type 

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Market Demand (US$ Mn) Analysis 2015 – 2019 and Forecast, 2020 – 2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020 – 2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Chemical Industry Outlook 

        8.1.2. Global GDP Outlook 

        8.1.3. Global Healthcare Market Overview 

        8.1.4. Other Industrial Value Added Industry 

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Top Companies Historical Growth 

        8.2.2. Demand From Chemicals Companies

        8.2.3. Demand from Construction Industry

    8.3. Global Urbanization Growth Outlook

    8.4. Value Chain

            8.4.1.1. List of Manufacturers

            8.4.1.2. List of Suppliers

            8.4.1.3. List of End Users 

    8.5. Supply Demand Analysis

            8.5.1.1. Production Capacity Analysis

            8.5.1.2. Production Analysis By Region 

            8.5.1.3. Consumption Analysis By Region

            8.5.1.4. Net Trade Analysis           

    8.6. Import Vs Sales Price Analysis

    8.7. Raw Material Analysis

            8.7.1.1. Availability

            8.7.1.2. List of Substitute Materials

    8.8. Product Type Vs End-use Criss-cross Analysis

    8.9. Market Dynamics

        8.9.1. Drivers

        8.9.2. Restraints

        8.9.3. Opportunity Analysis

9. Global Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030, By Product Type  

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2015 – 2019

    9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2020 – 2030

        9.3.1. Polytetrafluoroethylene (PTEF)

        9.3.2. Polyvinylidene Fluoride (PVDF)

        9.3.3. Polyvinyl Fluoride (PVF)

        9.3.4. Fluorinated Ethylene Propylene (FEP)

        9.3.5. Polychlorotrifluoroethylene (PCTFE)

        9.3.6. Perfluoroalkoxypolymer (PFA)

        9.3.7. Others

    9.4. Market Attractiveness Analysis By Product Type  

10. Global Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030, By Application  

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2015 – 2019

    10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2020 – 2030

            10.3.1.1. Medical Devices 

            10.3.1.2. Catheter

            10.3.1.3. Introducer

            10.3.1.4. Others

        10.3.2. Hospital Disposable 

            10.3.2.1. Medical Gloves

            10.3.2.2. Blood Bags

            10.3.2.3. Surgical Drape Set

            10.3.2.4. Others

        10.3.3. Pharma Packaging 

            10.3.3.1. Vials

            10.3.3.2. Bottles

            10.3.3.3. Blister Packaging

            10.3.3.4. Syringes

            10.3.3.5. Others

    10.4. Market Attractiveness Analysis By Application

11. Global Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015 – 2019

    11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2020 – 2030

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019

    12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

            12.4.1.1. By Country

            12.4.1.2. U.S.

            12.4.1.3. Canada

        12.4.2. By Product Type 

        12.4.3. By Application

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product Type 

        12.5.3. By Application

    12.6. Market Trends

    12.7. Key Market Participants - Intensity Mapping

    12.8. Drivers and Restraints - Impact Analysis

13. Latin America Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019

    13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

            13.4.1.1. By Country

            13.4.1.2. Brazil

            13.4.1.3. Mexico

            13.4.1.4. Rest of Latin America

        13.4.2. By Product Type 

        13.4.3. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product Type 

        13.5.3. By Application

    13.6. Market Trends

    13.7. Key Market Participants - Intensity Mapping

    13.8. Drivers and Restraints - Impact Analysis

14. Europe Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019

    14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

            14.4.1.1. By Country

            14.4.1.2. Germany

            14.4.1.3. Italy

            14.4.1.4. France

            14.4.1.5. U.K.

            14.4.1.6. Spain

            14.4.1.7. Russia

            14.4.1.8. Rest of Europe

        14.4.2. By Product Type 

        14.4.3. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product Type 

        14.5.3. By Application

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

15. South Asia & Pacific Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019

    15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

            15.4.1.1. By Country

            15.4.1.2. India

            15.4.1.3. ASEAN

            15.4.1.4. Australia & New Zealand 

            15.4.1.5. Rest of South Asia

        15.4.2. By Product Type 

        15.4.3. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product Type 

        15.5.3. By Application

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. East Asia Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019

    16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

            16.4.1.1. By Country

            16.4.1.2. China

            16.4.1.3. Japan

            16.4.1.4. South Korea

        16.4.2. By Product Type 

        16.4.3. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product Type 

        16.5.3. By Application

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019

    17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028

            17.4.1.1. By Country

            17.4.1.2. GCC Countries

            17.4.1.3. South Africa

            17.4.1.4. Turkey

            17.4.1.5. Rest of Middle East and Africa

        17.4.2. By Product Type 

        17.4.3. By Application

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product Type 

        17.5.3. By Application

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Key and Emerging Countries Fluoropolymers Market for Healthcare Analysis 

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. U.S. Fluoropolymers Market for Healthcare Analysis

        18.2.1. By Product Type 

        18.2.2. By Application

    18.3. Canada Fluoropolymers Market for Healthcare Analysis

        18.3.1. By Product Type 

        18.3.2. By Application

    18.4. Mexico Fluoropolymers Market for Healthcare Analysis

        18.4.1. By Product Type 

        18.4.2. By Application

    18.5. Brazil Fluoropolymers Market for Healthcare Analysis

        18.5.1. By Product Type 

        18.5.2. By Application

    18.6. Germany Fluoropolymers Market for Healthcare Analysis

        18.6.1. By Product Type 

        18.6.2. By Application

    18.7. Italy Fluoropolymers Market for Healthcare Analysis

        18.7.1. By Product Type 

        18.7.2. By Application

    18.8. France Fluoropolymers Market for Healthcare Analysis

        18.8.1. By Product Type 

        18.8.2. By Application

    18.9. U.K. Fluoropolymers Market for Healthcare Analysis

        18.9.1. By Product Type 

        18.9.2. By Application

    18.10. Spain Fluoropolymers Market for Healthcare Analysis

        18.10.1. By Product Type 

        18.10.2. By Application

    18.11. Russia Fluoropolymers Market for Healthcare Analysis

        18.11.1. By Product Type 

        18.11.2. By Application

    18.12. BENELUX Fluoropolymers Market for Healthcare Analysis

        18.12.1. By Product Type 

        18.12.2. By Application

    18.13. NORDICS Fluoropolymers Market for Healthcare Analysis

        18.13.1. By Product Type 

        18.13.2. By Application

    18.14. China Fluoropolymers Market for Healthcare Analysis

        18.14.1. By Product Type 

        18.14.2. By Application

    18.15. Japan Fluoropolymers Market for Healthcare Analysis

        18.15.1. By Product Type 

        18.15.2. By Application

    18.16. S. Korea Fluoropolymers Market for Healthcare Analysis

        18.16.1. By Product Type 

        18.16.2. By Application

    18.17. India Fluoropolymers Market for Healthcare Analysis

        18.17.1. By Product Type 

        18.17.2. By Application

    18.18. ASEAN Fluoropolymers Market for Healthcare Analysis

        18.18.1. By Product Type 

        18.18.2. By Application

    18.19. ANZ Fluoropolymers Market for Healthcare Analysis

        18.19.1. By Product Type 

        18.19.2. By Application

    18.20. GCC Countries Fluoropolymers Market for Healthcare Analysis

        18.20.1. By Product Type 

        18.20.2. By Application

    18.21. Turkey Fluoropolymers Market for Healthcare Analysis

        18.21.1. By Product Type 

        18.21.2. By Application

    18.22. Northern Africa Fluoropolymers Market for Healthcare Analysis

        18.22.1. By Product Type 

        18.22.2. By Application

    18.23. South Africa Fluoropolymers Market for Healthcare Analysis

        18.23.1. By Product Type 

        18.23.2. By Application

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies (Fluoropolymers)

    19.2. Market Concentration

    19.3. Market Share Analysis of Key Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product foot print by Players

        19.4.3. Channel Foot Print by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Pricing Analysis by Competition

    20.3. Competition Benchmarking

    20.4. Competition Deep Dive 

        20.4.1. The Chemours Company

            20.4.1.1. Overview

            20.4.1.2. Product Portfolio

            20.4.1.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.1.4. Sales Footprint

            20.4.1.5. Strategy Overview

                20.4.1.5.1. Marketing Strategy

                20.4.1.5.2. Product Strategy

                20.4.1.5.3. Channel Strategy

        20.4.2. Arkema Group

            20.4.2.1. Overview

            20.4.2.2. Product Portfolio

            20.4.2.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.2.4. Sales Footprint

            20.4.2.5. Strategy Overview

                20.4.2.5.1. Marketing Strategy

                20.4.2.5.2. Product Strategy

                20.4.2.5.3. Channel Strategy

        20.4.3. Solvay

            20.4.3.1. Overview

            20.4.3.2. Product Portfolio

            20.4.3.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.3.4. Sales Footprint

            20.4.3.5. Strategy Overview

                20.4.3.5.1. Marketing Strategy

                20.4.3.5.2. Product Strategy

                20.4.3.5.3. Channel Strategy

        20.4.4. DAIKIN INDUSTRIES, Ltd.

            20.4.4.1. Overview

            20.4.4.2. Product Portfolio

            20.4.4.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.4.4. Sales Footprint

            20.4.4.5. Strategy Overview

                20.4.4.5.1. Marketing Strategy

                20.4.4.5.2. Product Strategy

                20.4.4.5.3. Channel Strategy

        20.4.5. ASAHI GLASS CO., LTD.

            20.4.5.1. Overview

            20.4.5.2. Product Portfolio

            20.4.5.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.5.4. Sales Footprint

            20.4.5.5. Strategy Overview

                20.4.5.5.1. Marketing Strategy

                20.4.5.5.2. Product Strategy

                20.4.5.5.3. Channel Strategy

        20.4.6. 3M Company

            20.4.6.1. Overview

            20.4.6.2. Product Portfolio

            20.4.6.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.6.4. Sales Footprint

            20.4.6.5. Strategy Overview

                20.4.6.5.1. Marketing Strategy

                20.4.6.5.2. Product Strategy

                20.4.6.5.3. Channel Strategy

        20.4.7. Saint-Gobain

            20.4.7.1. Overview

            20.4.7.2. Product Portfolio

            20.4.7.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.7.4. Sales Footprint

            20.4.7.5. Strategy Overview

                20.4.7.5.1. Marketing Strategy

                20.4.7.5.2. Product Strategy

                20.4.7.5.3. Channel Strategy

        20.4.8. Dongyue Group Ltd.

            20.4.8.1. Overview

            20.4.8.2. Product Portfolio

            20.4.8.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.8.4. Sales Footprint

            20.4.8.5. Strategy Overview

                20.4.8.5.1. Marketing Strategy

                20.4.8.5.2. Product Strategy

                20.4.8.5.3. Channel Strategy

        20.4.9. Honeywell International Inc

            20.4.9.1. Overview

            20.4.9.2. Product Portfolio

            20.4.9.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.9.4. Sales Footprint

            20.4.9.5. Strategy Overview

                20.4.9.5.1. Marketing Strategy

                20.4.9.5.2. Product Strategy

                20.4.9.5.3. Channel Strategy

        20.4.10. Clariant

            20.4.10.1. Overview

            20.4.10.2. Product Portfolio

            20.4.10.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.10.4. Sales Footprint

            20.4.10.5. Strategy Overview

                20.4.10.5.1. Marketing Strategy

                20.4.10.5.2. Product Strategy

                20.4.10.5.3. Channel Strategy

        20.4.11. Mitsui Chemicals

            20.4.11.1. Overview

            20.4.11.2. Product Portfolio

            20.4.11.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.11.4. Sales Footprint

            20.4.11.5. Strategy Overview

                20.4.11.5.1. Marketing Strategy

                20.4.11.5.2. Product Strategy

                20.4.11.5.3. Channel Strategy

        20.4.12. Lonza Group

            20.4.12.1. Overview

            20.4.12.2. Product Portfolio

            20.4.12.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.12.4. Sales Footprint

            20.4.12.5. Strategy Overview

                20.4.12.5.1. Marketing Strategy

                20.4.12.5.2. Product Strategy

                20.4.12.5.3. Channel Strategy

        20.4.13. DIC Corporation

            20.4.13.1. Overview

            20.4.13.2. Product Portfolio

            20.4.13.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.13.4. Sales Footprint

            20.4.13.5. Strategy Overview

                20.4.13.5.1. Marketing Strategy

                20.4.13.5.2. Product Strategy

                20.4.13.5.3. Channel Strategy

        20.4.14. Polyone Corporation

            20.4.14.1. Overview

            20.4.14.2. Product Portfolio

            20.4.14.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.14.4. Sales Footprint

            20.4.14.5. Strategy Overview

                20.4.14.5.1. Marketing Strategy

                20.4.14.5.2. Product Strategy

                20.4.14.5.3. Channel Strategy

        20.4.15. Kaneka Corporation

            20.4.15.1. Overview

            20.4.15.2. Product Portfolio

            20.4.15.3. Profitability by Market Segments (Product/Channel/Region)

            20.4.15.4. Sales Footprint

            20.4.15.5. Strategy Overview

                20.4.15.5.1. Marketing Strategy

                20.4.15.5.2. Product Strategy

                20.4.15.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

 

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 02: Global Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 03: Global Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Table 04: Global Fluoropolymers Market for Healthcare Size Volume (KT) and Value (US$ Mn) Forecast by Region, 2015–2030

Table 05: North America Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030

Table 06: North America Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 07: North America Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 08: North America Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Table 09: Latin America Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030

Table 10: Latin America Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 11: Latin America Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 12: Latin America Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Table 13: Europe Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030

Table 14: Europe Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 15: Europe Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 16: Europe Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Table 17: East Asia Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030

Table 18: East Asia Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 19: East Asia Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 20: East Asia Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Table 21: South Asia Pacific Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030

Table 22: South Asia Pacific Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 23: South Asia Pacific Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 24: South Asia Pacific Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Table 26: MEA Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030

Table 27: MEA Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030

Table 28: MEA Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Historical Market Volume (KT) Analysis, 2015-2019

Figure 02: Global Current and Future Market Volume (KT) Analysis, 2020-2030

Figure 03: Fluoropolymers Market for Healthcare Historical Value (US$ Mn), 2015 – 2019

Figure 04: Fluoropolymers Market for Healthcare Value (US$ Mn) Forecast, 2020 – 2030

Figure 05: Fluoropolymers Market for Healthcare Absolute $ Opportunity, 2015 to 2020 and 2030

Figure 06: Global Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 07: Global Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 08: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PTFE Segment

Figure 09: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PVDF Segment

Figure 10: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PVF Segment

Figure 11: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by FEP Segment

Figure 12: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PCTFE Segment

Figure 13: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PFA Segment

Figure 14: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Others Segment

Figure 15: Global Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 16: Global Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 17: Global Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 18: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Medical Devices Segment

Figure 19: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Hospital Disposable Segment

Figure 20: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Pharma Packaging Segment

Figure 21: Global Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Figure 22: Global Fluoropolymers Market for Healthcare Share and BPS Analysis by Region– 2020 & 2030

Figure 23: Global Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Region, 2020 - 2030

Figure 24: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by North America Segment

Figure 25: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Latin America Segment

Figure 26: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Europe Segment

Figure 27: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by East Asia Segment

Figure 28: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by South Asia & Pacific Segment

Figure 29: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by MEA Segment

Figure 30: Global Fluoropolymers Market for Healthcare Attractiveness Analysis by Region, 2020-2030

Figure 31: North America Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030

Figure 32: North America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030

Figure 33: North America Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030

Figure 34: North America Fluoropolymers Market for Healthcare Absolute $ Opportunity by U.S. Segment

Figure 35: North America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Canada Segment

Figure 36: North America Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 37: North America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 38: North America Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 39: North America Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 40: North America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 41: North America Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Figure 42: Latin America Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030

Figure 43: Latin America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030

Figure 44: Latin America Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030

Figure 45: Latin America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Brazil Segment

Figure 46: Latin America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Mexico Segment

Figure 47: Latin America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Brazil Segment

Figure 48: Latin America Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 49: Latin America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 50: Latin America Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 51: Latin America Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 52: Latin America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 53: Latin America Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Figure 54: Europe Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030

Figure 55: Europe Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030

Figure 56: Europe Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030

Figure 57: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment

Figure 58: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment

Figure 59: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment

Figure 60: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment

Figure 61: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment

Figure 62: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment

Figure 63: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment

Figure 64: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment

Figure 65: Europe Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 66: Europe Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 67: Europe Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 68: Europe Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 69: Europe Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 70: Europe Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Figure 71: East Asia Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030

Figure 72: East Asia Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030

Figure 73: East Asia Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030

Figure 74: East Asia Fluoropolymers Market for Healthcare Absolute $ Opportunity by China Segment

Figure 75: East Asia Fluoropolymers Market for Healthcare Absolute $ Opportunity by Japan Segment

Figure 76: East Asia Fluoropolymers Market for Healthcare Absolute $ Opportunity by China Segment

Figure 77: East Asia Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 78: East Asia Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 79: East Asia Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 80: East Asia Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 81: East Asia Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 82: East Asia Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Figure 83: South Asia Pacific Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030

Figure 84: South Asia Pacific Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030

Figure 85: South Asia Pacific Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030

Figure 86: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by India Segment

Figure 87: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by ASEAN Segment

Figure 88: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by India Segment

Figure 89: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by ASEAN Segment

Figure 90: South Asia Pacific Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 91: South Asia Pacific Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 92: South Asia Pacific Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 93: South Asia Pacific Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 94: South Asia Pacific Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 95: South Asia Pacific Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Figure 96: MEA Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030

Figure 97: MEA Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030

Figure 98: MEA Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030

Figure 99: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by GCC Countries Segment

Figure 100: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by Turkey Segment

Figure 101: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by GCC Countries Segment

Figure 102: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by Turkey Segment

Figure 103: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by GCC Countries Segment

Figure 104: MEA Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030

Figure 105: MEA Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030

Figure 106: MEA Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030

Figure 107: MEA Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030

Figure 108: MEA Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030

Figure 109: MEA Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Fluoropolymers in Healthcare Market